Cargando…
Adjunct prednisone therapy for patients with community-acquired pneumonia: a randomized, placebo-controlled multicenter trial
Autores principales: | Blum, CA, Nigro, N, Briel, M, Schuetz, P, Ullmer, E, Suter-Widmer, I, Winzeler, B, Bingisser, R, Elsaesser, H, Drozdov, D, Arici, B, Urwyler, SA, Refardt, J, Tarr, P, Wirz, S, Thomann, R, Baumgartner, C, Duplain, H, Burki, D, Zimmerli, W, Rodondi, N, Mueller, B, Christ-Crain, M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4470455/ http://dx.doi.org/10.1186/cc14205 |
Ejemplares similares
-
Corticosteroid treatment for community-acquired pneumonia - the STEP trial: study protocol for a randomized controlled trial
por: Blum, Claudine A, et al.
Publicado: (2014) -
Influence of Prednisone on Inflammatory Biomarkers in Community‐Acquired Pneumonia: Secondary Analysis of a Randomized Trial
por: Raess, Natalie, et al.
Publicado: (2021) -
Copeptin levels and commonly used laboratory parameters in hospitalised patients with severe hypernatraemia - the “Co-MED study”
por: Nigro, Nicole, et al.
Publicado: (2018) -
The effect of glucose dynamics on plasma copeptin levels upon glucagon, arginine, and macimorelin stimulation in healthy adults: Data from: Glucacop, Macicop, and CARGO study
por: Atila, Cihan, et al.
Publicado: (2022) -
Predictors for length of hospital stay in patients with community-acquired Pneumonia: Results from a Swiss Multicenter study
por: Suter-Widmer, Isabelle, et al.
Publicado: (2012)